In fact, this stratified analysis showed a trend to statistical significance between lower DFS in those patients with the presence of Bmi-1 in plasma in more advanced stages of the disease and the remainder.
← all excerpts
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
1
—
—